Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CompumedicsASX:CMP -2.22%58 Days Sales Outstanding is 89.92 as of Dec. 2025, which is 31% below its 10-year median of 130.96. GuruFocus rates ASX:CMP with a GF Score™ of 58/100 and a GF Value™ of A$0.32 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Compumedics ranks worse than 72.26% on this metric.
Compumedics's average Accounts Receivable for the
six
months ended in Dec. 2025 was A$15.26 Mil. Compumedics's Revenue for the
six
months ended in Dec. 2025 was A$30.98 Mil.
Hence, Compumedics's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 89.92.
The historical rank and industry rank for Compumedics's Days Sales Outstanding or its related term are showing as below:
ASX:CMP'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 84.27 Med: 130.96 Max: 150.08
Current: 87.68
During the past 13 years, Compumedics's highest Days Sales Outstanding was 150.08. The lowest was 84.27. And the median was 130.96.
ASX:CMP's Days Sales Outstanding is ranked worse than 72.26% of 811
companies
in the Medical Devices & Instruments industry
Industry Median: 66.27
vs ASX:CMP: 87.68
Compumedics's Days Sales Outstanding
increased
from Dec. 2024 (84.95) to Dec. 2025 (89.92).
Compumedics (ASX:CMP) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Compumedics Days Sales Outstanding Related Terms
Compumedics Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Compumedics's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:CMP vs ABT, SYK, MDT: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Compumedics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Compumedics Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Compumedics's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Compumedics's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Compumedics (ASX:CMP) has a Days Sales Outstanding of 89.92 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Compumedics and its competitors. This is 31% below median its historical median of 130.96. Over the past decade, Compumedics' Days Sales Outstanding has ranged from 84.27 to 150.08. According to the industry distribution chart, Compumedics ranks #586 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 72.3%.
Is Compumedics' Days Sales Outstanding too high?
Compumedics' current Days Sales Outstanding of 89.92 is 31% below median its 10-year median of 130.96. Over the past 10 years, this metric has ranged from a low of 84.27 to a high of 150.08. The Medical Devices & Instruments industry median Days Sales Outstanding is 66.27. Compumedics' value of 89.92 is 35.7% above this industry median. Based on the distribution chart, Compumedics ranks #586 out of 811 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Compumedics has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Compumedics' Days Sales Outstanding compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Compumedics ranks #586 out of 811 companies for Days Sales Outstanding. This places Compumedics in the lower half of its industry. The industry median Days Sales Outstanding is 66.27. Compumedics' value of 89.92 is 35.7% above this benchmark. Historically, Compumedics' own Days Sales Outstanding has ranged from 84.27 to 150.08 over the past decade. While the company's 10-year median is 130.96 vs. the industry median of 66.27, Compumedics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 66.27, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Compumedics's current Days Sales Outstanding of 89.92 is 35.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Compumedics and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 66.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Compumedics's current Days Sales Outstanding is 89.92, which is 31% below median its own 10-year median of 130.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compumedics stock overvalued right now?
Based on GuruFocus' analysis, Compumedics (ASX:CMP) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.32, compared to a current price of A$0.22 — trading 31.3% below its estimated fair value. The current Days Sales Outstanding is 89.92, which is 31% below median its 10-year median of 130.96 and 35.7% above the Medical Devices & Instruments industry median of 66.27. Compumedics' overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Compumedics (ASX:CMP), the current Days Sales Outstanding is 89.92 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Compumedics (ASX:CMP) Overvalued in 2026?
Based on GuruFocus' analysis, Compumedics stock appears to be undervalued.
The current stock price of A$0.22 is trading 31.3% below its estimated GF Value™ of A$0.32.
GuruFocus considers Compumedics to be Possible Value Trap.
Key valuation signals for ASX:CMP:
Days Sales Outstanding: 89.92 (31% below median its 10-year median of 130.96)
GF Value™: A$0.32 vs. price of A$0.22 (31.3% below fair value)
Industry Position: 35.7% above the Medical Devices & Instruments median (#586 of 811)
No single metric tells the full story. See the ASX:CMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Compumedics Ltd is a medical device company. It is engaged in the development, manufacturing, and commercialization of diagnostic technologies for sleep, brain, and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of America, Australia and Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
58GF Score
Get the complete analysis for ASX:CMP
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CMP has been successfully added to your 
